Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?

被引：1

作者：

Abdallah, Mostafa ^{[1
]}

Reichard, Kaaren ^{[1
]}

Gangat, Naseema ^{[1
]}

Tefferi, Ayalew ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

BLOOD CANCER JOURNAL | 2024年 / 14卷 / 01期

关键词：

TP53; MUTATIONS; PREVALENCE;

D O I：

10.1038/s41408-024-01027-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 15 条

[11] Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation [J].

Pasca, Sergiu ;

Haldar, Saurav D. ;

Ambinder, Alexander ;

Webster, Jonathan A. ;

Jain, Tania ;

Dalton, W. Brian ;

Prince, Gabrielle T. ;

Ghiaur, Gabriel ;

Dezern, Amy E. ;

Gojo, Ivana ;

Smith, B. Douglas ;

Karantanos, Theodoros ;

Schulz, Cory ;

Stokvis, Kristin ;

Levis, Mark J. ;

Jones, Richard J. ;

Gondek, Lukasz P. .

HAEMATOLOGICA, 2024, 109 (03) :948-952

[12] WHO-defined 'myelodysplastic syndrome with isolated del(5q)′ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations [J].

Patnaik, M. M. ;

Lasho, T. L. ;

Finke, C. M. ;

Gangat, N. ;

Caramazza, D. ;

Holtan, S. G. ;

Pardanani, A. ;

Knudson, R. A. ;

Ketterling, R. P. ;

Chen, D. ;

Hoyer, J. D. ;

Hanson, C. A. ;

Tefferi, A. .

LEUKEMIA, 2010, 24 (07) :1283-1289

[13] Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q) [J].

Rufer, Axel ;

Angermann, Hubert ;

Benz, Rudolf ;

Bonadies, Nicolas ;

Calderoni, Antonello ;

Cantoni, Nathan ;

Efthymiou, Anna ;

Escher, Robert ;

Favre, Genevieve ;

Friess, Dorothea ;

Gschwend, Andreas ;

Himmelmann, Andreas ;

Holbro, Andreas ;

Keller, Peter ;

Kouroupi, Eirini ;

Lehmann, Thomas ;

Pedarnig, Nikolaus ;

Rigamonti, Veronique ;

Samii, Kaveh ;

Schmidt, Adrian ;

Schafer, Hans-Peter ;

Sperb, Roland ;

Stussi, Georg ;

Winkler, Annette ;

Zenhausern, Reinhard ;

Goede, Jeroen S. .

HEMASPHERE, 2022, 6 (07)

[14] Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms [J].

Sperling, Adam S. ;

Guerra, Veronica A. ;

Kennedy, James A. ;

Yan, Yuanqing ;

Hsu, Joanne, I ;

Wang, Feng ;

Nguyen, Andrew T. ;

Miller, Peter G. ;

McConkey, Marie E. ;

Barrios, Vanessa A. Quevedo ;

Furudate, Ken ;

Zhang, Linda ;

Kanagal-Shamanna, Rashmi ;

Zhang, Jianhua ;

Little, Latasha ;

Gumbs, Curtis ;

Daver, Naval ;

DiNardo, Courtney D. ;

Kadia, Tapan ;

Ravandi, Farhad ;

Kantarjian, Hagop ;

Garcia-Manero, Guillermo ;

Futreal, P. Andrew ;

Ebert, Benjamin L. ;

Takahashi, Koichi .

BLOOD, 2022, 140 (16) :1753-1763

[15] TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q) [J].

Tefferi, Ayalew ;

Fleti, Farah ;

Chan, Onyee ;

Al Ali, Najla H. ;

Al-Kali, Aref ;

Begna, Kebede H. ;

Foran, James M. ;

Badar, Talha ;

Khera, Nandita ;

Shah, Mithun ;

Hiwase, Devendra ;

Padron, Eric ;

Sallman, David A. ;

Pardanani, Animesh ;

Arber, Daniel A. ;

Orazi, Attilio ;

Reichard, Kaaren K. ;

He, Rong ;

Ketterling, Rhett P. ;

Gangat, Naseema ;

Komrokji, Rami .

BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) :1243-1248

← 1 2 →